Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 37879

AbstractMaterial and MethodsResultsDiscussionConclusionAcknowledgementReferencesTable and FiguresDOI and Others
Readers' Comments (0) Article in PDF Audio Visual Citation Manager Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Bhanu K Bhakhri

"The Journal of Clinical and Diagnostic Research (JCDR) has been in operation since almost a decade. It has contributed a huge number of peer reviewed articles, across a spectrum of medical disciplines, to the medical literature.
Its wide based indexing and open access publications attracts many authors as well as readers
For authors, the manuscripts can be uploaded online through an easily navigable portal, on other hand, reviewers appreciate the systematic handling of all manuscripts. The way JCDR has emerged as an effective medium for publishing wide array of observations in Indian context, I wish the editorial team success in their endeavour"



Dr Bhanu K Bhakhri
Faculty, Pediatric Medicine
Super Speciality Paediatric Hospital and Post Graduate Teaching Institute, Noida
On Sep 2018




Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dematolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011

Important Notice

Original article / research
Year : 2012 | Month : August | Volume : 6 | Issue : 6 | Page : 1014 - 1017

Topical Diltiazem is Superior to Topical Lignocaine in the Treatment of Chronic Anal Fissure: Results of A Prospective Comparative Study

Hanumanthappa M.B, Rithin Suvarna, Guruprasad Rai D

1. Associate Professor, Department of Surgery, 2. Associate Professor, Department of Surgery, 3. Assistant Professor, Department of Surgery, AJ Institute Of Medical Sciences, Mangalore India.

Correspondence Address :
Dr. Hanumanthappa M.B.
Associate Professor, Department of Surgery,
AJ institute of medical sciences, Kuntikana,
Mangalore 575004, India.
Phone: 9845170266
E-mail: mb.hanumanthappa@gmail.com, fltgopi@gmail.com,
drgururai@rediffmail.com

Abstract

Introduction: Fissure in ano is a troubling and painful condition that affects a great majority of the population the world over. Chronic anal fissures are associated with persistent hypertonia and spasm of the internal anal sphincter and they have conventionally been treated surgically. However, concerns have been raised about the risk of faecal incontinence after surgical sphicterotomy. In this study, we have explored topical 2% diltiazem as an effective and a safe alternative method to surgical treatment.

Materials and methods: In this prospective comparative study, 200 patients with chronic anal fissure from a single centre were included. They were randomly divided into the test group and the control group, with 100 patients in each group. The test group was instructed to apply 2% topical diltiazem ointment and control group was instructed to apply topical 2% Lignocaine twice daily for 6 consecutive weeks. They were asked to apply the medicine just inside the anal canal and 1cm around the anus circumferentially. The assessment was done at the 2nd, 4th and the 6th weekends for fissure healing, pain relief, bleeding control, control of discharge/perianal itching and for the side effects of the medicines.

Results: Complete healing of the fissure was observed in 72% of the patients in the test group against 23% in the control group by the end of 6 weeks (P< 0.0001). The pain relief was also good as the pain score in the test group dropped from 80 (mean) to 5 (mean) over the 6 weeks time. 80% of the test group cases experienced absent bleeding by the end of the 6th week as compared to 42% in the control group (P<0.001). 90% of the subjects in the test group reported a significant reduction in the discharge and the perianal pruritis as compared to 50 % in the control group (P<0.0001). 3 patients had a mild headache, while 10 patients experienced slight perianal pruritis. In the 1 year follow up, 4.28% subjects in the test group reported recurrence of the symptoms against 34.78% in the control group.

Conclusion: We conclude that 2% topical diltiazem is quite effective in the treatment of chronic fissure in ano.

Statistical analysis used: Chi square and P-value (SPSS software version 17).

Keywords

Fissure-in-ano, Sphincterotomy, Diltiazem

How to cite this article :

Hanumanthappa M.B, Rithin Suvarna, Guruprasad Rai D. TOPICAL DILTIAZEM IS SUPERIOR TO TOPICAL LIGNOCAINE IN THE TREATMENT OF CHRONIC ANAL FISSURE: RESULTS OF A PROSPECTIVE COMPARATIVE STUDY. Journal of Clinical and Diagnostic Research [serial online] 2012 August [cited: 2018 Oct 21 ]; 6:1014-1017. Available from
http://jcdr.net/back_issues.asp?issn=0973-709x&year=2012&month=August&volume=6&issue=6&page=1014-1017&id=2322

Introduction
Anal Fissure (AF) is a linear tear in the anal canal, which is distal to the dentate line (1) and it causes considerable morbidity (2). It is a common condition which affects all the age groups, but it is particularly common among young adults (1),(3). The aetiology is unclear. The main pathology appears to be persistent hypertonia and spasm of the internal anal sphincter that results in mucosal ischaemia (3), (4), (5). Acute AF usually heals with simple measures such as stool softeners and dietary modifications. But chronic AF usually doesn’t respond to such measures and a treatment is usually required, that is aimed at reducing the internal sphincter spasm with minimal complications (2). Chronic AF has traditionally been treated by surgical sphincterotomy (1),(6). However, concerns have been raised about the risk of permanent anal incontinence (2),(4). Therefore, pharmacological means to treat chronic anal fissures have been explored (4). The initial enthusiasm for chemical sphincterotomy with topical glyceryl trinitrate has waned because of side effects, particularly headache (6).

In a study which was conducted by Carapeti et al.,(6),(9) on fissure in ano by using topical diltiazem, fissure healing was noted in 67% of the cases (7), (8). In another study, Knight et al., (1) reported fissure healing in 73% of the cases. In this study, topical 2% diltiazem ointment has been explored as an effective and a safe alternative method of chemical sphincterotomy.

Material and Methods

This study was carried out at AJ Medical College Hospital, Mangalore from January 2009 to Dec 2011. 200 patients with chronic Anal Fissure (AF) were enrolled in this comparative, prospective clinical study which was cleared by the local ethical committee. A written informed consent was obtained from the patients and they were given the choice to pull out from the study at any point if they wished to. The treatment protocol was considered to be dishonored if a patient didn’t comply with the treatment as he/she was advised.

The inclusion criteria were:
patients who were aged between ≥18 years and ≤65 years; the presence of chronic anal fissure formore than 6 weeks that had failed to resolve with simple measures (stool softeners, a high fibre diet and a warm sitz bath); the physical examination had revealed fibrotic anal fissure with induration at the edges, an external skin tag, and exposure of the horizontal fibres of the internal anal sphincter on the floor. The exclusion criteria were any history of reaction to topical agents and associated co-morbidity such as ischaemic heart disease, hypertension, diabetes mellitus, anal fistula, haemorrhoides, perianal abscess, inflammatory bowel disease, HIV-related fissure, tuberculosis ulcer, leukaemic ulcer, pregnancy and lactation.

The chosen patients were treated as outpatients. They underwent a detailed clinical examination which included a digital rectal and proctoscopic examination. Sigmoidoscopy and colonoscopy were performed as and when they were necessary. They were randomized into the test group and the control group, with 100 patients in each group. They were subjected to the treatment with 2% topical diltiazem ointment for the test group and topical 2% lignocaine for the control group, twice daily for 6 consecutive weeks. The subjects were instructed to apply the medicine (about a size of pea) to just inside the anal canal and 1cm around the anus circumferentially by using the tip of their index fingers. The patients were encouraged to eat a high fibre diet and to use warm sitz baths.

They were called for follow up at the 2nd, 4th and 6th weekends during the course of the treatment and then bimonthly for a year. The parameters which were recorded at each visit were fissure healing, pain relief, control of the bleeding, control of the discharge and itching, any side effects and recurrence. The healing of the fissures was assessed visually and the intensity of the pain was assessed from a visual analogue score. The healing was defined as a complete disappearance of the fissure on examination. Each patient was supplied with a pain score chart and he/she was educated on how to daily mark the level of pain on it. These charts were graded from 0 to 100 and they were marked at one end as 0- (no pain) and at the other end as 100- (worst pain). The disease was termed as recurrent if either the symptoms and/or the fissure reappeared 1 month after the 6 weeks course of the topical application.

The data was collected and analyzed statistically by using the SPSS, version 17 software. The p values were calculated by using the Chi-square test.

Results

In this study, the ages of the patients were fairly similar in both the groups (Table/Fig 1). In both the groups, pain was the main presenting symptom, followed by bleeding per-rectum, anal discharge and pruritis [Table/ Fig 2]. 54%-58% of the cases had associated constipation, which is a common cause of fissure. Posterior midline fissure was the commonest location and in most of the cases, there were external skin tags, indurated edges and exposed internal sphincter muscles on the floor. At the end of the 2nd, 4th and the 6th weeks, the test group and the control group were evaluated and compared. The parameters which were compared were fissure healing, pain response, bleeding response, discharge and peri-anal itching and side effects.

Fissure healing: Complete healing of the fissure occurred in 72% of the patients in the test group against 23% in the control group by the end of 6 weeks (P<0.0001, statistically highly significant) (Table/Fig 3) and (Table/Fig 4). The pain score in the test group dropped from 80 (mean) to 5 (mean) in 6 weeks time. A maximal effect was observed in the first 4 weeks (Table/Fig 5).

Bleeding response:
The bleeding response was much better in the test group. Eighty percent of the test group cases experienced a significant fall in the bleeding by the end of the 6th weeks as compared to 42% in the control group (P<0.001 statistically significant).

Discharge and pruritis:
There was also a significant reduction in the discharge and the perianal pruritis as compared to those in the control group. In 90 of the 100 cases in the test group, the discharge and pruritis were absent, against 50 cases in the control group (P<0.0001, highly significant).

Adverse effects of the medicines:
Mild headache was experienced by 3% of the patients in the test group, while none of the cases in the control group reported about it (P<0.0001). All of them responded to paracetamol. Perianal itching was another side effect which was reported by 10% of the cases from the test group as compared to 4% in the control group (P<0.0001) (Table/Fig 6). The pruritis was mild and it didn’t require any treatment. All the patients in the test and the control groups completed the full 6 weeks course of the treatment. However, 7 of the 72 fissure healers in the test (diltiazem) group and two among the 23 fissure healers in the control group didn’t turn up for the follow up, while the rest completed the full 1 year follow up.

Recurrences:
Recurrence was observed in 3 of the 65 (4.61%) cases in the test group and in 8 out of the 21 (38%) cases in the control group.

Discussion

Anal fissure is one of the common causes of severe anal pain and it causes considerable morbidity (19). The posterior midline is the commonest site, followed by the anterior midline, particularly in females (3).Fissure is often initiated by constipation (9). In females, it frequently occurs during pregnancy and following childbirth (9). There is an associated spasm of the underlying internal sphincter muscle which results in severe pain and impaired fissure healing. An acute fissure (less than a month’s duration) usually heals spontaneously or with simple measures like a high fibre diet, adequate water intake, and warm sitz baths (1),(9). The chronic anal fissures are not usually amicable to the aforementioned simple conservative measures (1). A number of therapies have been described-non-operative and operative. The non-operative methods include the injection of botulin toxin to the fissure, oral nifedipine, the topical application of Glyceryl Trinitrate (GTN) and topical diltiazem ointment (9).

Topical GTN is the most extensively tried non-surgical treatment for chronic anal fissure (1),(2),(10). The topical GTN ointment or a GTN patch which is applied to the anal verge results in the healing of approximately two-thirds of the chronic anal fissures (11),(12). But, side effects such as headache and dizziness are common with nitrates, which may limit their application and reduce the patient compliance (12). Besides, the tolerance to nitrates is a well recognized phenomenon (12). Another drawback of the GTN therapy is the high recurrence rate which is associated with it (2). Nifedipine and dilitiazem are calcium channel blockers which act by blocking the slow L-type calcium channels in the smooth muscle, thus causing relaxation (1). A number of studies have reported fissure healing in 60% to 75% of the cases with topical diltiazem (6),(7),(13),(14). Carapeti et al., (6),(9) and Knight et al., (1) observed a fissure healing rate of 67% and 73% respectively in their studies.

They have also been tried successfully in the treatment of chronic AF that has failed to respond to GTN (8),(15). The topical diltiazem cream causes less headache and fewer side effects than the GTN ointment, without a significant difference in the healing rates between the two agents (6),(16). Also, the recurrence rate has been known to be lower with topical diltiazem (16),(17),(18),(19).

Conclusion

In our study, fissure healing was found in 72% of the cases who received topical diltiazem. The pain relief was satisfactory in a majority of the cases. Headache and perianal itching were the two common side effects which were reported by some of our subjects. However, they were mild and tolerable. One of the drawbacks which were observed was the patient compliance, as the duration of the treatment was quite long i.e. 6 weeks. We conclude that 2% topical diltiazem is quite effective in the treatment of chronic fissure in ano. It may be considered as a first line treatment for chronic fissure in ano.

Acknowledgement

We would like to thank all the consultant surgeons at the AJ Medical College Hospital, Mangalore, for allowing us to analyzetheir cases. We are very grateful to Dr. Nanjesh for his help with the statistical analysis. The authors confirm that there are no known conflicts of interest which are associated with this publication and that there has been no financial support for this work that could have influenced its outcome.

References

1.
Knight JS, Birks M, Farouk R. Topical diltiazem ointment in the treatment of chronic anal fissure. Br J Surg. 2001 Apr; 88(4):553-6.
2.
Pravin Gupta J. The treatment of fissure in ano- revisited. Afr Health Sci. 2004 April; 4(1): 58–62.
3.
Leong APK. Pharmacological treatment of anal fissure – A future role in the primary care. Singapore Med J .2003; 44(3): 136-37.
4.
Ward DI, Miller BJ, Schahe PJ. Cut or paste? The use of glyceryl trinitrate in the treatment of acute and chronic anal fissures. Aust N Z J Surg .2000; 70:19-21.
5.
Zuberi BF, Rajput MR, Abro H, Shaikh SA. A randomised trial of the glyceryl trinitrate ointment and the nitroglycerin patch in the healing of anal fissures. Int J Colorectal Dis .2000; 15:243-5.
6.
Carapeti EA, Kamm MA, Phillips RKS. Topical diltiazem and bethanecol decrease the anal sphincter pressure and heal the anal fissures without side effects. Dis Colon Rectum. 2000; 43:1359-62.
7.
Jonas M, Speake W, Scholefield JH. Dilitiazem heals glyceryl trinitrate — resistant chronic anal fissures: A prospective study. Dis Colon Rectum .2002; 45:1091-5.
8.
Kocher HM, Steward M, Leather AJ, Cullen PT. A randomised clinical trial which assessed the side-effects of glyceryl trinitrate and diltiazem hydrochloride in the treatment of chronic anal fissures. Br J Surg .2002; 89:413-7.
9.
. Carapeti EA, Kamm MA, Evans BK, Phillips RKS. Topical diltiazem and bethanechol decrease the anal sphincter pressure without side effects. Gut. 1999; 45:719-22.
10.
Utzig MJ, Kroesen AJ, Buhr HJ. Concepts in the pathogenesis and the treatment of chronic anal fissures—a review of the literature. The American Journal of Gastroenterology. 2003; 98: 968–74.
11.
Hisham MA. A comparative study on oral and topical nifedipine in the treatment of chronic anal fissures. Sudanese Journal Of Public Health. 2012 (Oct); 5(4). 12] Golfam F, Golfam P, Khalaj A,Mortaz S S S. The effect of topi cal nifedipine in the treatment of chronic anal fissures. Acta Med icaI ranica. 2010; 48(5): 295-99.
13.
Jonas M, Scholefield JH. Anal fissure. Gastroenterol Clin North Am. 2001; 30(1):167-81.
14.
Antropoli C, Perrotti P, Rubino M, Martino A, De stefano G, Migliore G, et al. Nifedipine for local use in the conservative treatment of anal fissures: Preliminary results of a multicenter study. Dis Colon Rectum. 1999; 42(8):1011-5.
15.
Perrotti P, Bove A, Antropoli C, Molino D, Antropoli M, Balzano A, et al. Topical Nifedipine with lidocaine ointment vs. active control for the treatment of chronic anal fissure: results of a prospective, randomized, double-blind study. Dis Colon Rectum .2002; 45(11):1468-75.
16.
Bhardwaj R,Parker MC. Modern perspectives in the treatment of chronic anal fissures. Ann R Coll Surg Engl. 2007 July; 89(5): 472–78.
17.
Dasgupta R, Franklin I, Pitt J, Dawson PM. The successful treatment of chronic anal fissures with the diltiazem gel. Colorect Dis.2002; 4:20–2.
18.
Griffin N, Acheson AG, Jonas M, Scholefield JH. Long-term follow up of the trial patients who were treated with diltiazem for anal fissure. Colorect Dis. 2002; 2002(Suppl 1):20.
19.
Bielecki K, Kolodziejczak M. A prospective randomized trial of diltiazem and glyceryltrinitrate ointment in the treatment of chronic anal fissure. Colorect Dis. 2003; 5:256–7.

DOI and Others

ID: JCDR/2012/4294:2322

Financial OR OTHER COMPETING INTERESTS:
None.


Date of Submission: Mar 19, 2011
Date of Peer Review: Mar 30, 2011
Date of Acceptance: Jul 05, 2012
Date of Publishing: Aug 10, 2012

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2016: 132.37
  • SCOPUS
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • EBSCOhost
  • Embase & EMbiology
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com